Back to search

Article

Selective Sensitivity of Ph-like B-ALL to BRG1 Inhibition Reveals a Novel Targeted Therapy Strategy

2025-07-11

Abstract excerpt

<h4>Summary</h4> Despite therapeutic advances, high-risk subtypes of B-cell acute lymphoblastic leukemia (B-ALL) such as Philadelphia chromosome-like (Ph-like) and KMT2A -rearranged ( KMT2A -R) remain a formidable clinical challenge. BRG1 (gene name SMARCA4 ), the ATPase subunit of the SWI/SNF chromatin-remodeling complex, has been extensively studied in solid tumors, where inactivating mutations are linked to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8aa569a-0599-52f6-92d9-3c59be254ba2
DOI
10.1101/2025.07.08.661805
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Selective Sensitivity of Ph-like B-ALL to BRG1 Inhibition Reveals a Novel Targeted Therapy StrategyDOI 10.1101/2025.07.08.661805
Select a neighboring publication to make it the new centre.